Invention Grant
- Patent Title: Human M2e peptide immunogens
- Patent Title (中): 人类M2e肽免疫原
-
Application No.: US13523710Application Date: 2012-06-14
-
Publication No.: US08932597B2Publication Date: 2015-01-13
- Inventor: Matthew Moyle , Jennifer Mitcham
- Applicant: Matthew Moyle , Jennifer Mitcham
- Applicant Address: US WA Seattle
- Assignee: Theraclone Sciences, Inc.
- Current Assignee: Theraclone Sciences, Inc.
- Current Assignee Address: US WA Seattle
- Agency: Cooley LLP
- Agent Ivor R. Elrifi
- Main IPC: A61K39/12
- IPC: A61K39/12 ; C07K16/10 ; A61K39/145 ; A61K39/00
Abstract:
The present invention provides novel peptide immunogens comprising influenza virus matrix 2 protein epitopes and related compositions and methods. The present invention relates to a composition comprising a peptide immunogen useful for the prevention and treatment of an influenza virus-mediated disease. The invention also relates to vaccines, immunogenic products and immunogenic compositions containing the peptide immunogens.
Public/Granted literature
- US20120258077A1 Human M2e Peptide Immunogens Public/Granted day:2012-10-11
Information query
